byiShook Opinion
Dec 2, 2024 - 10:05
Novocure stock catapulted early Monday after the company's cancer-treating device succeeded in a study of patients with pancreatic cancer. The post Novocure Launches 40% After Pancreatic Cancer Treatment Succeeds appeared first on Investor's Business Daily.
Novocure stock catapulted early Monday after the company's cancer-treating device succeeded in a study of patients with pancreatic cancer.
The post Novocure Launches 40% After Pancreatic Cancer Treatment Succeeds appeared first on Investor's Business Daily.